Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Organic compounds that consist of a phenol ring with an amino functional group substitution; amino functional groups consist of a nitrogen atom bonded to hydrogen atoms via single bonds.
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
ZM39923 hydrochloride is a research-grade small molecule that acts primarily as a JAK3 inhibitor (pIC50 = 7.1) and also potently inhibits tissue transglutaminase (TGM2) (IC50 ≈ 10 nM). It displays weaker activity against EGFR and JAK1 and minimal activity versus Lck and CDK4. Supplied as the hydrochloride salt with high reported purity, it is intended for laboratory research use only.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
ZM39923 hydrochloride is a small-molecule JAK3 inhibitor used in research. It displays JAK3 potency (pIC50 = 7.1) and also inhibits tissue transglutaminase (TGM2) with an IC50 of 10 nM; it is supplied as a 10 mM solution in DMSO and in solid quantities.
Small-molecule JAK3 inhibitor (pIC50 = 7.1).
Potent TGM2 inhibition (IC50 = 10 nM).
Available as 10 mM solution in DMSO and in solid forms.
Molecular formula C23H26ClNO.
Molecular weight 367.91 g/mol.
Purity >98.0% by HPLC.
For research use only.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
XMD8-92 (CAS 1234480-50-2) is a potent small-molecule inhibitor of mitogen-activated protein kinase 7 (MAPK7/BMK1) demonstrating a Kd of 80 nM and inhibiting EGF-induced BMK1 activation with an IC50 of 240 nM In cellular studies XMD8-92 suppresses proliferation and tumor xenograft growth of cancer cell lines linked to upregulation of tumor-suppressive miRNAs and downregulation of DCLK1 and several oncogenic targets In murine models it impedes the progression of lung and cervical cancer xenografts primarily by affecting cell cycle regulation and angiogenesis XMD8-92 remains under preclinical investigation for its potential in cancer research
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More